Monograph Details
|
|
Respiratory Tract
> Asthma/COPD
|
|
VENTOLIN HFA |
| Manufacturer |
|
GlaxoSmithKline Pharmaceuticals |
| Legal Classification |
|
Rx
|
| Pharmacological Class |
|
β2-agonist. |
| Generic Name |
|
Albuterol 90 micrograms/inh; metered-dose aerosol; contains hydrofluoroalkane; CFC-free. |
| Indications |
|
Bronchospasm. |
| Adults and Children |
|
<4 years: not recommended. ≥4 years: 2 inh every 4–6 hrs as needed; 1 inh every 4 hrs may suffice. Exercise-induced bronchospasm: 2 inh 15–30 minutes before exercise. |
| Precautions |
|
Avoid excessive use. Sensitivity to sympathomimetics. Discontinue if paradoxical bronchospasm, immediate hypersensitivity reactions, or cardiovascular effects occur. Cardiovascular disease (eg, coronary insufficiency, arrhythmias, hypertension). Diabetes. Hyperthyroidism. Seizure disorders. Reevaluate periodically. Elderly. Labor & delivery. Pregnancy (Cat.C). Nursing mothers: not recommended. |
| Interactions |
|
Avoid MAOIs, tricyclics within 14 days (increased cardiovascular effects). Oral sympathomimetics: not recommended. Antagonized by β-blockers. Monitor digoxin. Caution with other drugs that may lower serum potassium (eg, diuretics). |
| Adverse Reactions |
|
Tremor, nervousness, headache, dizziness, cough, hyperactivity, insomnia, weakness, tachycardia, epistaxis, hypokalemia, throat irritation, paradoxical bronchospasm; hypersensitivity reactions (eg, rash, urticaria, angioedema). |
| How Supplied |
|
Inhalation aerosol—18g (200 inh w. dose counter) |
| Additional Resources |
|
• Related Prescribing Note |
|
|
|
|
